NEW YORK, May 1, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ABIOMED, Inc. ("ABMD" or the "Company") (NASDAQ: ABMD) (CUSIP: 003654100). Investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 237.
The investigation concerns whether ABIOMED and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On May 1, 2014, Company announced in a press release that "on April 25, 2014, ABIOMED received a subpoena from the Boston regional office of the United States Department of Health and Human Services, Office of Inspector General requesting materials relevant to the Company's reimbursement of expenses and remuneration to healthcare providers during the period of July 2012 – December 2012. The Office of Inspector General has informed the Company that the subpoena currently relates to a civil investigation."
On this news, shares of ABIOMED fell $1.32, or more than 5.57%, on intraday trading to $22.37, on unusually heavy trading volume.
The Pomerantz Firm, with offices in New York, Chicago, San Diego, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf
Robert S. Willoughby
SOURCE Pomerantz LLP